Compound ID | 375
Class: Glycopeptide
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus, vancomycin-intermediate Staphylococcus aureus, and Enterococcus spp. |
| Description: | Chu DT, Ye T, Wang B, et al. Synthesis and Biological Properties of a Novel Series of Glycopeptide Antibacterial Agents. 49th-ICAAC 2009 |
| Institute where first reported: | LEAD Therapeutics (BioMarin Pharmaceutical, USA) |
| Year first mentioned: | 2009 |
| Development status: | Experimental |
| External links: |